ATARA BIOTHERAPEUTICS INC (ATRA)
US0465131078 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -276.13M | -228.30M | -340.14M | -306.62M | -290.98M | |||
| Depreciation Amortization | 4.83M | 5.65M | 9.35M | 8.33M | 7.07M | |||
| Change In Working Capital | 15.34M | -61.47M | 52.58M | 63.69M | -4.15M | |||
| Interest Paid | 447.00K | 340.00K | 30.00K | 60.00K | 50.00K | |||
| Taxes Paid | 2.00K | 20.00K | 20.00K | 10.00K | 0.00 | |||
| Other non cash items | 62.98M | 13.69M | 57.69M | 53.84M | 52.43M | |||
| OPERATING CASH FLOW | -192.98M | -270.43M | -220.52M | -180.76M | -235.63M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.22M | -4.19M | -10.58M | -4.51M | -5.73M | |||
| Other Investing Activity | 125.09M | 207.15M | 32.84M | -116.22M | 66.19M | |||
| INVESTING CASH FLOW | 123.87M | 202.96M | 22.26M | -120.73M | 60.46M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -947.00K | -520.00K | -250.00K | -390.00K | -490.00K | |||
| Stock Issued/Repurchased | 2.14M | 21.89M | 98.70M | 422.97M | 188.62M | |||
| Other Financing Activity | 821.00K | 31.71M | 5.50M | 4.99M | 660.00K | |||
| FINANCING CASH FLOW | 2.01M | 53.08M | 103.94M | 427.57M | 188.79M | |||
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | |||
| CHANGE IN CASH | -67.10M | -14.39M | -94.32M | 126.08M | 13.62M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -192.98M | -270.43M | -220.52M | -180.76M | -235.63M | |||
| Capital Expenditure | -1.22M | -4.19M | -10.58M | -4.51M | -5.73M | |||
| FREE CASH FLOW | -194.20M | -274.62M | -231.10M | -185.27M | -241.36M | |||
All data in USD